What is driving the growth of the Biopreservation market?

 

What is driving the growth of the biopreservation market?

The biopreservation market is expanding at a remarkable pace, supported by increasing demand for biobanking, regenerative medicine, and personalized drug discovery. In 2024, the market value was USD 6.40 billion. By 2034, it is forecasted to reach USD 24.57 billion, growing at a CAGR of 14.40% during 2025–2034.

The need for long-term preservation of cells, tissues, and organs is critical for clinical research and therapeutic applications. Additionally, the growth of stem cell therapy, cancer research, and fertility preservation is fueling adoption worldwide.

Biopreservation Market Size and Share

The market has seen accelerated growth in recent years due to rising investment in healthcare infrastructure and biomedical research.

  • Market Value (2024): USD 6.40 Billion

  • Forecast Value (2034): USD 24.57 Billion

  • CAGR (2025–2034): 14.40%

Regional Market Share:

  • North America leads due to advanced biobanking facilities and strong biotechnology research.

  • Europe holds significant share with strong government support for life sciences.

  • Asia Pacific is growing rapidly owing to increasing healthcare investments and population-based biobanking.

  • Latin America & Middle East and Africa are emerging markets with growing awareness and adoption.

Biopreservation Market Dynamics and Trends

The market is influenced by advancements in life sciences and global healthcare demands.

Key Drivers:

  • Increasing use of biobanking for personalized medicine.

  • Expanding applications of regenerative medicine and stem cell therapies.

  • Rising demand for fertility preservation and organ transplantation.

  • Technological advancements in biopreservation media and cryogenic storage.

Emerging Trends:

  • Development of AI-driven biobanking solutions for precision research.

  • Growing use of sustainable cryopreservation techniques.

  • Shift toward automated storage systems in research institutes and hospitals.

  • Strong collaboration between academic research and pharmaceutical companies.

Read full report: https://www.expertmarketresearch.com/reports/biopreservation-market/requestsample

Biopreservation Market Growth Outlook

Between 2025–2034, the market will continue to expand due to the rising adoption of cell-based therapies and growth in clinical trials for advanced therapies. Pharmaceutical companies are investing heavily in cryopreservation technologies to streamline drug discovery processes.

Furthermore, the rising global burden of chronic diseases is creating opportunities for biopreservation solutions to support long-term storage of biological samples for research and therapeutic use.

Market Opportunities and Challenges

Opportunities:

  • Expansion in regenerative medicine and immunotherapy research.

  • Growing investments in biobanking infrastructure across emerging economies.

  • Rising collaboration between academic institutions and biotech firms.

Challenges:

  • High costs associated with biopreservation equipment and maintenance.

  • Strict regulatory approvals for storage and handling of biological materials.

  • Technical complexities in ensuring long-term viability of preserved samples.

Recent Developments in the Biopreservation Market

  • BioLife Solutions, Inc. expanded its biopreservation media product line to meet global demand.

  • Thermo Fisher Scientific Inc. invested in cryopreservation equipment to strengthen its biobanking portfolio.

  • Exact Sciences Corporation advanced biopreservation solutions for cancer diagnostic research.

  • ThermoGenesis Holdings, Inc. launched next-gen cell processing systems for regenerative medicine.

  • MVE Biological Solutions introduced advanced cryogenic storage tanks to enhance sample safety.

Competitor Analysis

The biopreservation market is moderately consolidated, with major players focusing on innovation and partnerships.

Key Players:

  • BioLife Solutions, Inc. – Leader in biopreservation media solutions.

  • Thermo Fisher Scientific Inc. – Strong global presence in equipment and consumables.

  • Exact Sciences Corporation – Advancing cancer diagnostics with biopreservation.

  • Simport Scientific Inc. – Specialized in laboratory consumables.

  • ThermoGenesis Holdings, Inc. – Pioneer in cell processing systems.

  • Lifeline Scientific – Focused on organ preservation technology.

  • Princeton CryoTech – Known for cryogenic storage solutions.

  • MVE Biological Solutions – Major player in cryogenic equipment manufacturing.

Market Segmentation

By Product Type

  • Biopreservation Equipment

  • Biopreservation Media

  • Others

By Application

  • Regenerative Medicine

  • Biobank

  • Drug Discovery

  • Others

By End User

  • Hospitals

  • Biobank

  • Research and Academic Institutes

  • Others

By Region

  • North America

  • Europe

  • Asia Pacific

  • Latin America

  • Middle East and Africa

Frequently Asked Questions (FAQs)

Q1: What is the current size of the biopreservation market?
The global biopreservation market was valued at USD 6.40 billion in 2024 and is expected to grow to USD 24.57 billion by 2034, at a CAGR of 14.40%.

Q2: What factors are driving the growth of the biopreservation market?
The market is driven by the growing demand for biobanking, regenerative medicine, drug discovery, and long-term biological sample preservation.

Q3: Which region dominates the biopreservation market?
North America currently leads the market, supported by advanced research infrastructure and strong investments in regenerative medicine.

Q4: What are the major applications of biopreservation?
The primary applications include regenerative medicine, biobanking, drug discovery, and fertility preservation.

Q5: Who are the key players in the biopreservation market?
Leading players include BioLife Solutions, Thermo Fisher Scientific, Exact Sciences, ThermoGenesis Holdings, MVE Biological Solutions, and Princeton CryoTech.

Comments

Post a Comment

Popular posts from this blog

Age-Related Macular Degeneration Market: Market Growth and Future Demand (2034)

Image
 Expert Market Research uncovers a significant surge in the age-related macular degeneration market , with its growth being propelled by a rapidly aging global population and continuous pharmaceutical innovations. As medical advancements lead to better treatment outcomes and early diagnosis, the market is showing a promising expansion in terms of both size and share . Treatments such as Lucentis and Eylea are gaining popularity due to their efficacy, while new entrants are further diversifying the therapeutic landscape. This progressive trend is not only reshaping patient care but also stimulating research investments and biotech collaborations across major regions worldwide. Overview of the Age-Related Macular Degeneration Market Age-related macular degeneration (AMD) is a chronic eye disorder that causes blurred or reduced central vision due to thinning of the macula, a part of the retina. It is a leading cause of vision loss among individuals aged 50 and above. The increasing ...
Read more

What is driving the rapid growth of the Head and neck cancer therapeutics market?

Image
  The head and neck cancer therapeutics market is gaining significant momentum as the prevalence of head and neck cancers continues to rise globally. The growing incidence of risk factors such as tobacco use, alcohol consumption, and HPV-related infections has increased the demand for innovative therapeutic solutions. At the same time, continuous research in immunotherapy and targeted therapies is offering improved survival rates and better patient outcomes. In 2024, the global market reached a valuation of USD 1.67 billion . With advancements in personalized medicine, novel drug approvals, and increased cancer awareness, the market is projected to grow at a CAGR of 11.20% between 2025 and 2034 , reaching approximately USD 4.83 billion by 2034 . This report provides insights into the market size, share, therapy trends, regional distribution, key players, opportunities, challenges, and FAQs to answer real-world queries that decision-makers and patients are asking. Head and Neck C...
Read more

Healthcare Contract Manufacturing Market: Trend Analysis and Future Growth (2034)

Image
  Healthcare Contract Manufacturing Market Overview The healthcare contract manufacturing market has emerged as a critical backbone for the global medical device and pharmaceutical sectors. By outsourcing production, companies can focus on innovation, research, and core competencies while leveraging the expertise and scale of contract manufacturers. These third-party partners offer specialized services, from raw material processing to the assembly of complex medical devices, ensuring regulatory compliance and high-quality output. This model helps healthcare companies adapt quickly to market demands, introduce new products faster, and optimize production costs. As the demand for advanced diagnostics, medical devices, and pharmaceuticals grows, contract manufacturing continues to play a pivotal role in the healthcare supply chain. Expert Market Research on Healthcare Contract Manufacturing Market In the dynamic healthcare contract manufacturing landscape, partnering with industry exp...
Read more